SC 13G Filing

Company

Emmaus Life Sciences, Inc.

Filed

January 6, 2012

Accession Number

0001144204-12-001059

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →